CMS has unveiled its BALANCE model, a voluntary Medicare and Medicaid coverage pathway for GLP-1s that includes price negotiations and supplemental lifestyle support, with coverage beginning in 2026 for Medicaid and 2027 for Medicare Part D [2]
In gastric cancer peritoneal metastasis, SPP1 TAMs and THBS2 matrix CAFs (mCAFs) jointly construct a spatially dense immunosuppressive niche, further limiting T-cell access to tumor cores
Hara T, Hirasawa A, Ichimura A, Kimura I, Tsujimoto G
Epigenetic mechanisms involved in methamphetamine addiction
At the same time, in addition to being expressed in tumor cells, IDO is also expressed in stromal cells, such as fibroblasts and vascular endothelial cells (Haniffa et al., 2007
We anticipate that as more people utilize these medications, we will see larger clinical trials specifically targeting functional gastrointestinal disorders